Deutsche Bank raised the firm’s price target on 10x Genomics (TXG) to $23 from $17 and keeps a Hold rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXG:
- 10x Genomics reports Q1 EPS (10c), consensus (6c)
- 10x Genomics backs FY26 revenue view $600M-$625M, consensus $612.74M
- 10x Genomics price target raised to $32 from $22 at Canaccord
- 10x Genomics price target raised to $30 from $21 at BofA
- 10x Genomics announces Atera, a new in situ spatial biology platform